col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


75 Results       Page 1

 [1] 
Elsevier: Autoimmunity Reviews
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―09 Antiphospholipid syndrome in the era of COVID-19 - Two sides of a coin Naim Mahroum, Mona Habra, Mohamad Aosama Alrifaai, Yehuda Shoenfeld
2 [GO] 2024―Mar―13 Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination Yisha Li, Jie Wang, Shuang Liang, Yan Zhang, Zhe Feng, Guangyan Cai
3 [GO] 2023―Dec―29 Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines Altijana Hromić-Jahjefendić, Kenneth Lundstrom, Muhamed Adilović, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Ángel Serrano-Aroca, Vladimir N. Uversky
4 [GO] 2023―Aug―18 Increased incidence of rheumatoid arthritis after COVID-19 Juan Sebastian Marín, Enrique A. Mazenett-Granados, Juan Carlos Salazar-Uribe, Mauricio Sarmiento, John Fredy Suárez, Manuel Rojas, et al. (+5)
5 [GO] 2023―Jul―23 COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis Abolfazl Akbari, Alireza Hadizadeh, Muhammad Islampanah, Ensie Salavati Nik, Stephen L. Atkin, Amirhossein Sahebkar
6 [GO] 2023―Jul―15 Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of autoimmune imprinting and immunological host defense Ming Zheng
7 [GO] 2023―Apr―17 Insights into new-onset autoimmune diseases after COVID-19 vaccination Ming Guo, Xiaoxiao Liu, Xiangmei Chen, Qinggang Li
8 [GO] 2023―Apr―14 Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study Víctor Moreno-Torres, Vicente Soriano, Jorge Calderón-Parra, María Martínez-Urbistondo, Ana Treviño, Zayrho de San Vicente, et al. (+2)
9 [GO] 2023―Feb―03 COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus Nefeli Giannopoulou, Latika Gupta, Laura Andreoli, Daniele Lini, Elena Nikiphorou, Rohit Aggarwal, et al. (+2)
10 [GO] 2023―Feb―02 COVID-19 and autoimmune bullous diseases: Lessons learned Michael Kasperkiewicz, David T. Woodley
11 [GO] 2023―Feb―02 Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13) Xavier Bossuyt, Jean-Baptiste Vulsteke, Jan Van Elslande, Lise Boon, Greet Wuyts, Silke Willebrords, et al. (+9)
12 [GO] 2022―Nov―19 Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients. Pier Luigi Meroni, Stefania Croci, Paola Adele Lonati, Francesca Pregnolato, Lucia Spaggiari, Giulia Besutti, et al. (+9)
13 [GO] 2022―Oct―03 COVID-19 and the antiphospholipid syndrome Manuel Serrano, Gerard Espinosa, Antonio Serrano, Ricard Cervera
14 [GO] 2022―Aug―23 Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Sabrina Rosaria Paparo, Armando Patrizio, Eugenia Balestri, et al. (+6)
15 [GO] 2022―Apr―09 Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination Armando Patrizio, Silvia Martina Ferrari, Alessandro Antonelli, Poupak Fallahi
16 [GO] 2021―Dec―16 The impact of the COVID-19 pandemic on the global assessments of rheumatology clinimetrics: Data from a mobile application. A comment on article by Nagy E, et al.: “The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned” Nejc Tomšič, Matija Tomšič, Žiga Rotar, Alojzija Hočevar, Victor Savevski, Carlo F. Selmi
17 [GO] 2021―Dec―09 Autoantibodies and infection with SARS-CoV2 infection: The spectrum from association to clinical implication report of the 15th Dresden symposium on autoantibodies Jan Damoiseaux, Arad Dotan, Marvin J. Fritzler, Dimitrios P. Bogdanos, Pier Luigi Meroni, Dirk Roggenbuck, et al. (+5)
18 [GO] 2021―Nov―16 Could oxytocin reduce autoimmune disease in COVID-19? Phuoc-Tan Diep, Véronique de Kok
19 [GO] 2021―Nov―02 Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: “IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19” Alojzija Hočevar, Matija Tomšič
20 [GO] 2021―Oct―28 The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum Andreas Kronbichler, Duvuru Geetha, Rona M. Smith, Allyson C. Egan, Ingeborg M. Bajema, Ulf Schönermarck, et al. (+5)
21 [GO] 2021―Oct―28 The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned Eszter Nagy, Maria Infantino, Nicola Bizzaro, Hristina Andreeva, Hetty J. Bontkes, Xavier Bossuyt, et al. (+11)
22 [GO] 2021―Sep―10 The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases Luis J. Jara, Berenice López-Zamora, Irvin Ordoñez-González, María F. Galaviz-Sánchez, Caroline I. Gutiérrez-Melgarejo, Miguel A. Saavedra, et al. (+3)
23 [GO] 2021―Sep―09 Autoimmunity roots of the thrombotic events after COVID-19 vaccination Fatma Elrashdy, Murtaza M. Tambuwala, Sk. Sarif Hassan, Parise Adadi, Murat Seyran, Tarek Mohamed Abd El-Aziz, et al. (+19)
24 [GO] 2021―Sep―09 IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19 Laure Badier, Albanie Toledano, Tiphaine Porel, Sylvain Dumond, Julien Jouglen, Laurent Sailler, et al. (+3)
25 [GO] 2021―Aug―30 Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis Anuraag Jena, Shubhra Mishra, Parakkal Deepak, Praveen Kumar-M, Aman Sharma, Yusuf I. Patel, et al. (+4)
26 [GO] 2021―Jul―22 Antiphospholipid antibodies and COVID-19 Antonio La Cava
27 [GO] 2021―Jul―16 The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19 Elrashdy M. Redwan, Mohammed F. Alghamdi, Tarek Mohamed Abd El-Aziz, Parise Adadi, Alaa A.A. Aljabali, Diksha Attrish, et al. (+23)
28 [GO] 2021―Jul―15 Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma Marco Matucci Cerinic, Michael Hughes, Gloria Taliani, Bashar Kahaleh
29 [GO] 2021―Jul―03 COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? Abdorreza Naser Moghadasi
30 [GO] 2021―Jun―10 Autoimmunity and COVID-19 - The microbiotal connection Nurit Katz-Agranov, Gisele Zandman-Goddard
31 [GO] 2021―Jun―10 Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review Mayka Freire, Ariadna Andrade, Bernardo Sopeña, Maria Lopez-Rodriguez, Pablo Varela, Purificación Cacabelos, et al. (+2)
32 [GO] 2021―May―08 Zipper method is the emerging treatment option for severe Guillain-Barre syndrome related COVID-19 Ozlem Saritas Nakip, Selman Kesici, Benan Bayrakci
33 [GO] 2021―Apr―19 Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent Olivier Vollmer, Charles Tacquard, Yannick Dieudonné, Benoit Nespola, Laurent Sattler, Lélia Grunebaum, et al. (+14)
34 [GO] 2021―Mar―18 A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis Abdorreza Naser Moghadasi
35 [GO] 2021―Feb―21 Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data Chuanhui Xu, Zixi Yi, Ruyi Cai, Ru Chen, Bernard Yu-Hor Thong, Rong Mu
36 [GO] 2021―Feb―21 Molecular mimicry between SARS-CoV-2 and human proteins Yekbun Adiguzel
37 [GO] 2021―Feb―21 The SARS-CoV-2 as an instrumental trigger of autoimmunity Arad Dotan, Sylviane Muller, Darja Kanduc, Paula David, Gilad Halpert, Yehuda Shoenfeld
38 [GO] 2021―Jan―18 Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement Shaghayegh Shahmirzaei, Abdorreza Naser Moghadasi
39 [GO] 2021―Jan―18 Autoantibodies in COVID-19: frequency and function Zhao-wei Gao, Hui-zhong Zhang, Chong Liu, Ke Dong
40 [GO] 2020―Dec―15 Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. Gilles Kaplanski, Denis Bontemps, Pierre Esnault, Valery Blasco, Julien Carvelli, David Delarbre, et al. (+3)
41 [GO] 2020―Dec―13 Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward Alexandre Le Joncour, Corinne Frere, Isabelle Martin-Toutain, Paul Gougis, Pascale Ghillani-Dalbin, Georgina Maalouf, et al. (+7)
42 [GO] 2020―Oct―28 SARS-CoV-2, the autoimmune virus Gilad Halpert, Yehuda Shoenfeld
43 [GO] 2020―Oct―27 COVID-19 and Immune-Mediated Inflammatory Diseases: Why don't our patients get worse? Víctor M. Martínez-Taboada, Marcos López-Hoyos, Javier Crespo, José L. Hernández
44 [GO] 2020―Oct―22 Guillian Barré syndrome and COVID-19: Possible role of the cytokine storm Faraz S. Hussain, Mohamed A. Eldeeb, Derrick Blackmore, Zaeem A. Siddiqi
45 [GO] 2020―Sep―14 Screening neuromyelitis optica patients for COVID-19 infection Omid Mirmosayyeb, Saeed Vaheb, Mahdi Barzegar, Vahid Shaygannejad, Simona Bonavita, Mahsa Ghajarzadeh
46 [GO] 2020―Sep―14 What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? Enrico De Lorenzis, Gerlando Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello, Elisa Gremese
47 [GO] 2020―Aug―13 Risk of COVID-19 in celiac disease patients Fabiana Zingone, Anna D'Odorico, Greta Lorenzon, Ilaria Marsilio, Fabio Farinati, Edoardo Vincenzo Savarino
48 [GO] 2020―Jun―11 Molecular mimicry may explain multi-organ damage in COVID-19 Francesca Angileri, Sébastien Legare, Antonella Marino Gammazza, Everly Conway de Macario, Alberto JL Macario, Francesco Cappello
49 [GO] 2020―Jun―11 Covid-19 and autoimmunity Michael Ehrenfeld, Angela Tincani, Laura Andreoli, Marco Cattalini, Assaf Greenbaum, Darja Kanduc, et al. (+5)
50 [GO] 2020―May―05 Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? Nicoletta Del Papa, Gianluca Sambataro, Antonina Minniti, Francesca Pignataro, Roberto Caporali
51 [GO] 2020―May―05 How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion Piercarlo Sarzi-Puttini, Daniela Marotto, Marco Antivalle, Fausto Salaffi, Fabiola Atzeni, Giovanni Maconi, et al. (+5)
52 [GO] 2020―May―05 COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Serena Colafrancesco, Cristiano Alessandri, Fabrizio Conti, Roberta Priori
53 [GO] 2020―May―05 Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection Louise Cunningham, Ian Kimber, David Arthur Basketter, John Paul McFadden
54 [GO] 2020―May―05 Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? Spinello Antinori, Cecilia Bonazzetti, Guido Gubertini, Amedeo Capetti, Cristina Pagani, Valentina Morena, et al. (+4)
55 [GO] 2020―May―05 Convalescent plasma in Covid-19: Possible mechanisms of action Manuel Rojas, Yhojan Rodriguez, Diana M. Monsalve, Yeny Acosta-Ampudia, Bernardo Camacho, Juan Esteban Gallo, et al. (+7)
56 [GO] 2020―May―05 SARS-CoV-2 infection among patients with systemic autoimmune diseases Giacomo Emmi, Alessandra Bettiol, Irene Mattioli, Elena Silvestri, Gerardo Di Scala, Maria Letizia Urban, et al. (+2)
57 [GO] 2020―May―05 Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis Omer Gendelman, Howard Amital, Nicola Luigi Bragazzi, Abdulla Watad, Gabriel Chodick
58 [GO] 2020―May―04 Imatinib might constitute a treatment option for lung involvement in COVID-19 David Bernal-Bello, Beatriz Jaenes-Barrios, Alejandro Morales-Ortega, José Manuel Ruiz-Giardin, Virginia García-Bermúdez, Begoña Frutos-Pérez, et al. (+6)
59 [GO] 2020―May―04 Cytokine storm syndrome in severe COVID-19 Piero Ruscitti, Onorina Berardicurti, Annamaria Iagnocco, Roberto Giacomelli
60 [GO] 2020―May―04 Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review Jaume Alijotas-Reig, Enrique Esteve-Valverde, Cristina Belizna, Albert Selva-O'Callaghan, Josep Pardos-Gea, Angela Quintana, et al. (+3)
61 [GO] 2020―May―04 Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view Andreas Kronbichler, Maria Effenberger, Michael Eisenhut, Keum Hwa Lee, Jae Il Shin
62 [GO] 2020―May―04 Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy Paola Toniati, Simone Piva, Marco Cattalini, Emirena Garrafa, Francesca Regola, Francesco Castelli, et al. (+4)
63 [GO] 2020―May―04 Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms Federica Raucci, Adel Abo Mansour, Gian Marco Casillo, Anella Saviano, Francesco Caso, Raffaele Scarpa, et al. (+3)
64 [GO] 2020―May―04 Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions Yvan Jamilloux, Thomas Henry, Alexandre Belot, Sébastien Viel, Maxime Fauter, Thomas El Jammal, et al. (+3)
65 [GO] 2020―May―03 Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH? Mohammed S. Osman, Charmaine van Eeden, Jan Willem Cohen Tervaert
66 [GO] 2020―May―03 Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies Paolo Fagone, Rosella Ciurleo, Salvo Danilo Lombardo, Carmelo Iacobello, Concetta Ilenia Palermo, Yehuda Shoenfeld, et al. (+3)
67 [GO] 2020―May―01 Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood
68 [GO] 2020―May―01 Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons Guglielmo Lucchese, Agnes Flöel
69 [GO] 2020―May―01 The correlation between SARS-CoV-2 infection and rheumatic disease Zhao-wei Gao, Xi Wang, Fang Lin, Ke Dong
70 [GO] 2020―May―01 SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa
71 [GO] 2020―Apr―05 Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning Yehuda Shoenfeld
72 [GO] 2020―Apr―04 ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia Felice Rivellese, Edoardo Prediletto
73 [GO] 2020―Apr―04 The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood
74 [GO] 2020―Apr―03 What is the role of rheumatologists in the era of COVID-19? Daniela Marotto, Piercarlo Sarzi-Puttini
75 [GO] 2020―Mar―20 COVID-19 infection and rheumatoid arthritis: Faraway, so close! Ennio Giulio Favalli, Francesca Ingegnoli, Orazio De Lucia, Gilberto Cincinelli, Rolando Cimaz, Roberto Caporali
 [1] 

75 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec